Work

Implementing a Clinical Immunogenicity Strategy using Preclinical Risk Assessment Outputs

Year: 2022

Type: review

Source: Journal of Pharmaceutical Sciences

DOI: 10.1016/j.xphs.2022.01.032

Authors: Vibha Jawa, Jad Maamary, Michael Swanson, Shuli Zhang, Diana Montgomery

Institutions: Bristol-Myers Squibb (United States), Immunai (United States), Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4210366603

FWCI: 0.393

Cites: 60

Cited by: 22

Related to: 10